Ken Griffin En V Veno Medical Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in En V Veno Medical Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 37,400 shares of NVNO stock, worth $136,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,400
Previous 49,300
24.14%
Holding current value
$136,136
Previous $268,000
26.87%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVNO
# of Institutions
31Shares Held
3.71MCall Options Held
98.5KPut Options Held
6.1K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$2.38 Million0.4% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$2.27 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$2.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT478KShares$1.74 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.46 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $34.5M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...